CD4 and neoplasm: Thus, the inclusion of tumor-unrelated universal CD4 helper antigens (uniHELP) resulted in a clear “helper signature” on vaccine-induced CD8+ T cells, while this signature was marginally detectable in the case of tumor-specific helper neoantigens (neoHELP).